Stryker receives FDA clearance for Tritanium C Anterior Cervical Cage: 5 key notes

Stryker granted FDA clearance to Tritanium C Anterior Cervical Cage, a 3D printed interbody fusion cage.

Advertisement

Here are five things to know:

 

1. The Tritanium C Anterior Cervical Cage is constructed from the Tritanium In-Growth Technology, a highly porous titanium material designed for bone in-growth and biological fixation. Tritanium material may be able to wick or retain fluid.

 

2. The cage’s structure is designed to create a favorable environment for cell attachment and proliferation

 

3. Stryker’s proprietary approach to implant creation using additive manufacturing, AMagine, allows for the 3D printing.

 

4. Tritanium C Anterior Cervical Cage has an open central graft window and lateral window to help reduce stiffness of the cage and minimize subsidence. The large graft window also allows for bone graft containment. The cage has serrations on the superior and inferior surfaces for bidirectional fixation and to maximize surface area where the endplate makes contact with the cage.

 

5. Surgeons will have access to the cage in the fourth quarter of 2017.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.